HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Garry X Shen Selected Research

Sucrose (Saccharose)

1/2023Impact of anthocyanin component and metabolite of Saskatoon berry on gut microbiome and relationship with fecal short chain fatty acids in diet-induced insulin resistant mice.
7/2021Dose-Responses Relationship in Glucose Lowering and Gut Dysbiosis to Saskatoon Berry Powder Supplementation in High Fat-High Sucrose Diet-Induced Insulin Resistant Mice.
1/2021Saskatoon berry powder reduces hepatic steatosis and insulin resistance in high fat-high sucrose diet-induced obese mice.
8/2020Impact of Cyanidin-3-Glucoside on Gut Microbiota and Relationship with Metabolism and Inflammation in High Fat-High Sucrose Diet-Induced Insulin Resistant Mice.
1/2019Impact of Saskatoon berry powder on insulin resistance and relationship with intestinal microbiota in high fat-high sucrose diet-induced obese mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Garry X Shen Research Topics

Disease

12Inflammation (Inflammations)
10/2023 - 07/2006
9Insulin Resistance
10/2023 - 07/2006
7Atherosclerosis
08/2020 - 04/2005
5Body Weight (Weight, Body)
07/2021 - 10/2011
5Hyperglycemia
01/2021 - 12/2003
5Type 2 Diabetes Mellitus (MODY)
01/2018 - 11/2005
5Mitochondrial Diseases (Mitochondrial Disease)
12/2012 - 01/2010
3Coronary Artery Disease (Coronary Atherosclerosis)
07/2006 - 06/2002
2Dysbiosis
07/2021 - 08/2020
2Necrosis
01/2021 - 10/2017
2Neoplasms (Cancer)
08/2020 - 12/2003
2Gestational Diabetes (Gestational Diabetes Mellitus)
01/2018 - 01/2017
2Cardiovascular Diseases (Cardiovascular Disease)
01/2016 - 01/2010
2Hypercholesterolemia
12/2012 - 07/2006
2Vascular System Injuries
01/2010 - 10/2007
2Hemorrhage
01/2010 - 01/2006
2Diabetic Angiopathies (Diabetic Angiopathy)
01/2010 - 12/2003
2Death (Near-Death Experience)
07/2006 - 11/2005
2Thrombosis (Thrombus)
07/2006 - 01/2006
2Coronary Disease (Coronary Heart Disease)
11/2005 - 04/2003
2Diabetes Mellitus
11/2005 - 04/2003
1Hyperlipidemias (Hyperlipidemia)
01/2021
1Fatty Liver
01/2021
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2020
1Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced)
01/2017
1Pre-Eclampsia (Preeclampsia)
01/2017
1Premature Birth (Birth, Premature)
01/2017
1Birth Weight (Birth Weights)
09/2014
1Gestational Weight Gain
09/2014
1Hypertriglyceridemia
12/2012
1Hypoalphalipoproteinemias (Hypoalphalipoproteinemia)
12/2012
1B-Cell Lymphoma (Lymphoma, B Cell)
02/2012
1Wounds and Injuries (Trauma)
01/2012
1Right Ventricular Hypertrophy
10/2011
1Hypertrophy
10/2011
1Heart Failure
10/2011
1Pulmonary Hypertension
10/2011
1Sarcoma (Soft Tissue Sarcoma)
09/2010

Drug/Important Bio-Agent (IBA)

10CholesterolIBA
10/2023 - 04/2003
9Triglycerides (Triacylglycerol)IBA
10/2023 - 04/2003
8Glucose (Dextrose)FDA LinkGeneric
10/2023 - 01/2019
8Plasminogen Activators (Plasminogen Activator)IBA
10/2023 - 11/2008
7Insulin (Novolin)FDA Link
10/2023 - 01/2019
6Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
10/2023 - 10/2017
5LipidsIBA
01/2023 - 08/2020
5Sucrose (Saccharose)IBA
01/2023 - 01/2019
5Plasminogen Activator Inhibitor 1IBA
08/2020 - 04/2003
4PowdersIBA
01/2023 - 01/2019
4EnzymesIBA
01/2021 - 01/2010
4Reactive Oxygen Species (Oxygen Radicals)IBA
03/2010 - 04/2005
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2023 - 01/2019
3cyanidin-3-O-beta-glucopyranosideIBA
01/2023 - 11/2012
3LDL Receptors (LDL Receptor)IBA
08/2020 - 01/2016
3Lipoproteins (Lipoprotein)IBA
12/2012 - 06/2002
3oxidized low density lipoproteinIBA
09/2010 - 04/2003
3hirulog-like peptideIBA
01/2010 - 07/2003
3ThrombinFDA Link
10/2007 - 07/2003
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
07/2006 - 11/2005
2Volatile Fatty AcidsIBA
10/2023 - 01/2023
2Cell Adhesion Molecule-1IBA
01/2019 - 10/2017
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2019 - 10/2017
2Advanced Glycation End ProductsIBA
12/2012 - 03/2010
2Proteins (Proteins, Gene)FDA Link
02/2012 - 01/2012
2Peptides (Polypeptides)IBA
10/2011 - 10/2007
2Heparin (Liquaemin)FDA LinkGeneric
01/2010 - 01/2006
2bivalirudin (Angiomax)FDA Link
01/2010 - 01/2006
2VLDL LipoproteinsIBA
10/2008 - 04/2003
2Transforming Growth Factor beta (TGF-beta)IBA
12/2006 - 07/2003
1isobutyric acidIBA
10/2023
1AcidsIBA
10/2023
1Anthocyanins (Anthocyanin)IBA
01/2023
1protocatechuic acidIBA
01/2023
1Alanine Transaminase (SGPT)IBA
01/2021
1CollagenIBA
01/2021
1Tumor Biomarkers (Tumor Markers)IBA
01/2021
1AMP-Activated Protein KinasesIBA
08/2020
1PrebioticsIBA
08/2020
1ibrutinibIBA
03/2020
1A-factor (Streptomyces)IBA
01/2018
1A 17 (A-17)IBA
11/2016
1Phytosterols (Plant Sterols)IBA
01/2016
1N 30IBA
09/2014
1CarbohydratesIBA
09/2014
1Blood Glucose (Blood Sugar)IBA
08/2014
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
08/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2013
1DNA (Deoxyribonucleic Acid)IBA
12/2012
1NADPH Oxidases (NAD(P)H oxidase)IBA
11/2012
1LDL glycated lipoproteinsIBA
11/2012
1Caspase 3 (Caspase-3)IBA
02/2012
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2012
1Cardiolipins (Cardiolipin)IBA
10/2011
1Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2010

Therapy/Procedure

2Cesarean Section (Caesarean Section)
01/2017 - 12/2008
2Catheters
01/2010 - 07/2003
1Oral Administration
01/2023
1Fat-Restricted Diet (Diet, Fat Restricted)
07/2021
1Therapeutics
03/2020
1Diet Therapy (Therapy, Diet)
01/2016
1Endurance Training
04/2015